Skip to main content

Advertisement

Table 1 Patient demographics, by transplanting hospital

From: Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients

  Pediatric transplants Adult transplants
Characteristic (n =192) (n =990)
Age (yr) – median (IQR) 11 (6, 15) 52 (42, 61)
Sex: male – n (%) 104 (54) 583 (59)
Race/Ethnicity – n (%)   
Caucasian 101 (53) 761 (77)
Hispanic 31 (17) 27 (3)
Asian Pacific-Islander 19 (10) 59 (6)
Black 6 (3) 17 (2)
Native American 2 (1) 8 (1)
Other 22 (12) 53 (5)
Unknown 11 (6) 65 (7)
Underlying Disease – n (%)   
ALL 67 (35) 107 (11)
AML 34 (18) 341 (34)
MDS 12 (6) 206 (21)
NHL 7 (4) 107 (11)
CML 6 (3) 36 (4)
HD 1 (1) 30 (3)
Other 65 (34) 163 (17)
Stem cell source – n (%)   
Bone marrow 102 (53) 155 (16)
PBSC 36 (19) 743 (75)
Cord blood 54 (28) 92 (9)
Donor – n (%)   
Sibling 52 (27) 300 (30)
Unrelated 80 (42) 523 (53)
Cord 54 (28) 92 (9)
Haploidentical 6 (3) 68 (7)
Conditioning regimen – n (%)   
Myeloablative 175 (91) 559 (57)
Nonmyeloablative 17 (9) 431 (44)
GVHD prophylaxis – n (%)   
CSP or FK506, with MTX 106 (55) 360 (36)
MMF regimen 74 (39) 539 (54)
Other/none 12 (6) 91 (9)
Inpatient daysa – median (IQR) 41 (31, 55) 18 (5, 28)
  1. Abbreviations: IQR (interquartile range), ALL (acute lymphoblastic leukemia), AML (acute myeloid leukemia), MDS (myelodysplastic syndrome), NHL (non-Hodgkin lymphoma), CML (chronic myeloid leukemia), HD (Hodgkin’s lymphoma), PBSC (peripheral blood stem cells), GVHD (graft-versus-host disease), CSP (cyclosporine), FK506 (tacrolimus), MTX (methotrexate), MMF (mycophenolate mofetil)
  2. aWhile under observation (i.e. prior to censorship)